BioPerfectus

BioPerfectus (SSE: 688399) stands at the forefront of the molecular diagnostics industry, with a specialization in diagnostics for infectious diseases and womens and childrens health. Founded in 2010, BioPerfectus consistently emphasizes R&D, manufacturing, and the distribution of in-vitro diagnostic reagents and instruments. Through strategic planning, the company has seamlessly integrated its efforts from the development and production of upstream core materials to downstream diagnostic services. With a diverse portfolio of over 600 products, BioPerfectus caters to a broad spectrum of medical institutions, CDCs, and independent clinical laboratories across more than 100 countries and regions. Further solidifying its position in molecular...

In vitro diagnostic,rt-pcr,nucleic extraction system,biotechnology,health care,molecular diagnostic,infectious diesease,virology,poct,and laboratory

Bioperfectus operates in the Medical device industry.

Bioperfectus's HQ phone number is +86 052386201616

Bioperfectus's revenue is 11m - 100m

Bioperfectus has 51 - 200 employees.